Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #531 to #580.
- 5-MeO-pyr-T (1 revision)
- 5-MeS-DMT (1 revision)
- 5-Methoxy-diisopropyltryptamine (1 revision)
- 5-Methylcytosine (1 revision)
- 5-Methylindole (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
- ALLHAT trial (1 revision)
- 60S ribosomal protein L19 (1 revision)
- ACOT7 (1 revision)
- 5-alpha-reductase deficiency case study one (1 revision)
- ALDH3A1 (1 revision)
- ABT-239 (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- ACRRM (1 revision)
- 5-alpha-reductase deficiency electrocardiogram (1 revision)
- AEGIS II Visit Scheduler (test mode) (1 revision)
- 5-alpha-reductase deficiency future or investigational therapies (1 revision)
- AKAP7 (1 revision)
- AKR7A3 (1 revision)
- ALDH4A1 (1 revision)
- ALDH16A1 (1 revision)
- ALD-52 (1 revision)
- ALDH1B1 (1 revision)
- ACSBG2 (1 revision)
- ALDH3B1 (1 revision)
- ALDH3B2 (1 revision)
- AKAP2 (1 revision)
- ACTIVE A Trial (1 revision)
- AM-855 (1 revision)
- ADM2 (1 revision)
- 5-alpha-reductase deficiency primary prevention (1 revision)
- ALDOC (1 revision)
- ACSL6 (1 revision)
- 5-alpha-reductase deficiency secondary prevention (1 revision)
- 5-alpha-reductase deficiency surgery (1 revision)
- ALG1 (1 revision)
- ALG12 (1 revision)
- 5-bromouracil (1 revision)
- 5-hydroxytryptophan (1 revision)
- ACSM2B (1 revision)
- ALOXE3 (1 revision)
- 5150 (Involuntary psychiatric hold) (1 revision)
- 5q- syndrome (1 revision)
- ALPHA (psychedelic) (1 revision)
- ALX1 (1 revision)
- ALPPL2 (1 revision)
- 6-Pyruvoyltetrahydropterin synthase deficiency (1 revision)
- AM-087 (1 revision)
- ACSS3 (1 revision)